Abstract
The results of Steven Schwartz and colleagues' study1 on human embryonic stem cell (hESC)-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy are very exciting; however, we have some concerns about the interpretation of the study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
